<DOC>
	<DOC>NCT00692341</DOC>
	<brief_summary>This study will evaluate the effects of mild and moderate impairment of hepatic function on the single-dose pharmacokinetics, safety and tolerability of AG-013736.</brief_summary>
	<brief_title>Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Diagnosis of reduced hepatic function (Child Pugh Classification A or B) Body Mass Index of 1832 kg/m2 History of febrile illness within 5 days prior to first dose Any condition possibly affecting drug absorption (e.g. gastrectomy) Positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>hepatic impairment</keyword>
</DOC>